Proto Labs Inc (PRLB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 200M 400M 600M FY10: 64.9M FY11: 98.9M FY12: 126M FY13: 163.1M FY14: 209.6M FY15: 264.1M FY16: 298.1M FY17: 344.5M FY18: 445.6M FY19: 458.7M FY20: 434.4M FY21: 488.1M FY22: 488.4M FY23: 503.9M FY24: 500.9M FY25: 533.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 90M 180M 270M FY10: 39.5M FY11: 59.6M FY12: 76.1M FY13: 101.7M FY14: 128.4M FY15: 154.4M FY16: 166.9M FY17: 193.8M FY18: 238.7M FY19: 235.3M FY20: 217.8M FY21: 222.7M FY22: 215.5M FY23: 222M FY24: 223.2M FY25: 237.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-105M -70M -35M 0 35M 70M 105M FY10: 15.9M FY11: 26.9M FY12: 34.9M FY13: 51.3M FY14: 60.5M FY15: 67.1M FY16: 61.8M FY17: 72.2M FY18: 88.9M FY19: 79.9M FY20: 59.8M FY21: 40.3M FY22: -98M FY23: 28.2M FY24: 19.9M FY25: 25.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-120M -80M -40M 0 40M 80M 120M FY10: 11M FY11: 18M FY12: 24M FY13: 35.3M FY14: 41.6M FY15: 46.5M FY16: 42.7M FY17: 51.8M FY18: 76.6M FY19: 63.7M FY20: 50.9M FY21: 33.4M FY22: -103.5M FY23: 17.2M FY24: 16.6M FY25: 21.2M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 150M 300M 450M FY10: 25.4M FY11: 39.3M FY12: 49.9M FY13: 61.4M FY14: 81.2M FY15: 109.7M FY16: 131.1M FY17: 150.6M FY18: 206.9M FY19: 223.4M FY20: 216.6M FY21: 265.4M FY22: 272.9M FY23: 281.9M FY24: 277.7M FY25: 296M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 50M 100M 150M FY10: 14M FY11: 23.5M FY12: 25.3M FY13: 48.4M FY14: 57.2M FY15: 64.1M FY16: 77.5M FY17: 81.7M FY18: 122.9M FY19: 116.1M FY20: 107M FY21: 55.2M FY22: 62.1M FY23: 73.3M FY24: 77.8M FY25: 74.5M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 25M 50M 75M FY10: 6.9M FY11: 4.5M FY12: 7.9M FY13: 29.7M FY14: 13.7M FY15: 19.7M FY16: 43.9M FY17: 49.1M FY18: 35.8M FY19: 53.8M FY20: 60M FY21: 21M FY22: 40.4M FY23: 45.2M FY24: 68.7M FY25: 59.7M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 10M 20M 30M FY10: 13.1M FY11: 13.9M FY12: 24.4M FY13: 25.9M FY14: 26.1M FY15: 26.3M FY16: 26.6M FY17: 26.8M FY18: 27.3M FY19: 27M FY20: 26.9M FY21: 27.7M FY22: 27.4M FY23: 26.2M FY24: 25.2M FY25: 24.2M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '11: 0.67 Q1 '12: 0.70 Q2 '12: 0.73 Q3 '12: 0.77 Q4 '12: 0.97 Q1 '13: 1.07 Q2 '13: 1.20 Q3 '13: 1.28 Q4 '13: 1.35 Q1 '14: 1.42 Q2 '14: 1.51 Q3 '14: 1.57 Q4 '14: 1.61 Q1 '15: 1.62 Q2 '15: 1.64 Q3 '15: 1.71 Q4 '15: 1.77 Q1 '16: 1.77 Q2 '16: 1.73 Q3 '16: 1.71 Q4 '16: 1.60 Q1 '17: 1.66 Q2 '17: 1.71 Q3 '17: 1.75 Q4 '17: 1.93 Q1 '18: 2.13 Q2 '18: 2.35 Q3 '18: 2.63 Q4 '18: 2.81 Q1 '19: 2.72 Q2 '19: 2.65 Q3 '19: 2.50 Q4 '19: 2.35 Q1 '20: 2.30 Q2 '20: 2.17 Q3 '20: 2.10 Q4 '20: 1.89 Q1 '21: 1.50 Q2 '21: 1.50 Q3 '21: 1.12 Q4 '21: 1.21 Q1 '22: 1.27 Q2 '22: 0.89 Q3 '22: 0.86 Q4 '22: -3.77 Q1 '23: -3.86 Q2 '23: -3.96 Q3 '23: -3.79 Q4 '23: 0.67 Q1 '24: 0.77 Q2 '24: 0.96 Q3 '24: 0.94 Q4 '24: 0.66 Q1 '25: 0.61 Q2 '25: 0.61 Q3 '25: 0.62 Q4 '25: 0.88 Q1 '26: 1.06 Q2 '26: 1.25 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.